Feedback Share Discussion Threads

[kenwrong] 08/1/2015 08:37

It's going to be a big year for Feedback, waiting for further updates on FDA approval.

[21trader] 24/12/2014 16:29

The market makers have killed it 1.35-1.85p spread they are having a laugh.

[kenwrong] 24/12/2014 10:19

mikealig think you'll find the real mileage in this stock has yet to materialise. Interview link with Dr Ganeshan here again: hxxp://www.tiptv.co.uk/ceo-interviews/interview-with-dr-balaji-ganeshan-the-scientific-director-of-feedback-plc-fdbk-lon/

[kenwrong] 08/12/2014 19:34

This will be of interest to Feedback holders. Published on Traders Own last week, an article from AuntMinnie.com on how texture analysis accurately differentiates between benign and malignant kidney lesions. Feedback are at the forefront of texture analysis with their TexRad technology.

AuntMinnie article here: hxxp://www.auntminnie.com/index.aspx?sec=rca&sub=rsna_2014&pag=dis&ItemID=109537&wf=6301

[tomboyb] 20/11/2014 13:17

Thanks for that Kenwrong -

[kenwrong] 20/11/2014 10:12

I would expect that the prospects and PT would be revisited by the broker once FBK get the FDA approval.

[21trader] 20/11/2014 09:37

2.1p is a bit on the low side not much of a incentive to buy when the offer is only a small % below the target price.

So what happens if the price jumped 15-20% and hits the broker target price...do they then say sell ??

[kenwrong] 20/11/2014 09:28

Broker note out today from Sanlam Securities, initiating a speculative buy rating and 2.1p price target. Published already on Traders Own - hxxp://tradersown.co.uk/company/278409/Feedback-Plc

[tomboyb] 17/11/2014 11:25

If they get FDA approval -

Someone I know has recently been diagnosed with Bowel cancer - Thankfully it was caught early. This can be treated effectively if caught early.

[21trader] 17/11/2014 11:20

Must be something big to show later mm's do not increase the bid from 1.5p to 1.6p out of generosity !

[mikealig] 14/11/2014 13:00

Have some of these from the 'old' days before they re-invented themselves. Never thought they'd be of much interest but watching the interview with Dr Balaji, there could still be some mileage in them.

GLA

[tomboyb] 13/11/2014 21:13

CT scan - 4mill scans

Very good interview -

hxxp://www.tiptv.co.uk/ceo-interviews/interview-with-dr-balaji-ganeshan-the-scientific-director-of-feedback-plc-fdbk-lon/

FDA approval in perhaps 3 months? It does look v interesting.

[21trader] 13/11/2014 15:12

Do people with £300 honestly expect to make a profit when they take one a wide
spread and commission in Aim smallcaps

19500 paid around 1.7p then sold 1.53p a few hours later.

Stick to horse racing or Casino the £50 you lost just might go on the winner
but you will never beat the mm's

[norbert colon] 13/11/2014 11:02

hxxp://www.tradersown.co.uk/blog/23343/Alan-Green-Discusses-Quindell-Qpp-And-Feedback-Fdbk-With-Justin-Waite-On-The-Advfn-Podcast

Huge potential here with TaxRad news and FDA approval etc around 3 months away.

Small speculative holding.

[tomboyb] 12/11/2014 09:28

It should be relatively easy to add -

Saves time and money which exactly what is needed in the NHS.

Detect and modify treatments for cancer patients.

[kenwrong] 12/11/2014 08:32

This is exciting, following Feedback on Twitter too @FeedbackPLC Looks like this is the start of a big journey for this company.

[tomboyb] 11/11/2014 19:28

And because TexRAD simply provides an additional layer of software analysis of the MRI and CT scans that already exist as part of routine clinical practice, it is non-invasive from the patient's point of view and potentially cost-effective to the healthcare provider."

The RextRad website -

hxxp://texrad.com/

Easily do-able. Interesting as a way of actually dealing with bowel cancer patients.

[21trader] 11/11/2014 14:31

Pump.....nobody chases dump quickly before you get trapped....the topinfo way

[topinfo] 11/11/2014 14:25

And this only days ago!!

Kenwrong
Posts: 23
Research
Opinion: Buy
Price: 1.43
Scientific Director interviewed
Wed 18:12

An excellent interview today with Dr Balaji Ganeshan, Scientific Director at Feedback PLC. Valued at just £2.7m, the company is on the threshold of securing FDA approval which will enable it to grow operationally in a market worth some $32bn in 2014.

Link to interview here:

[tomboyb] 11/11/2014 14:23

The technology is being evaluated in a number of prestigious research institutions and university hospitals around the world.


That is fascinating -

[tomboyb] 11/11/2014 14:17

FDBK -

It looks very interesting. Could change the nature of treating bowel cancer patients